(Q38221060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

18 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

Journal of Enzyme Inhibition and Medicinal Chemistry

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

321-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Structure-based drug discovery of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Design of zinc binding functions for carbonic anhydrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Metal binding functions in the design of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

New zinc binding motifs in the design of selective carbonic anhydrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

Carbonic Anhydrase and Matrix Metalloproteinase Inhibitors: Sulfonylated Amino Acid Hydroxamates with MMP Inhibitory Properties Act as Efficient Inhibitors of CA Isozymes I, II, and IV, andN-Hydroxysulfonamides Inhibit Both These Zinc Enzymes1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2014.913587

10.3109/14756366.2014.913587

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24939097%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference